Companies104 Funding$41.8B Rounds76 ▼1 mo Investors69 Eng roles4177 ● data fresh
VIX The Intelligent Venture Terminal beta

Evvy

fresh

Evvy

☆ Watch

Accelerate precision diagnostics and medicine for women's health observed

fresh · evidence 9d ago 7 sources no confidence data
53.7/100
Venture signal
scored above 38% of growth peers
Outlook Stable
Why this score? ↓

What we have established three decisions, kept apart

  1. 1 Identity verified Not recorded

    No person- or entity-level identity check is on record for this company. A name match is not one.

  2. 2 Evidence sufficient to publish Yes

    The inclusion bar: two or more independent sourced evidence families. This profile is published and listed. It is a statement about how much evidence we hold, and about nothing else.

  3. 3 Fit for a seed/Series-A sourcing buyer Not established

    We have not established fit. That is not a soft no and not a soft yes — it is unknown, and it is never counted as a qualified prospect.

Funding
$40M
2026-09-15
Adoption
no signal
downloads / week
Developer
not scored
momentum / 100
Hiring
no board
eng openings
Commercial
not checked
homepage

Traction

Current round

Opportunity & risk

↗ Strongest signal: funding_recency (18% of the score).

↓ Scored on 2 of 4 components — adoption, developer had no computable metric.

4 independent sources 0 promoted signals inspect the evidence →

Evaluation

How it's evaluated Four independent layers ▾

No single number decides. Layers can disagree — that's the point. New to this? →

Platform score derived
54/100
Founder self-assessment claimed
8/100
Investor ratings opinion
—
Expert ratings opinion
—
Rate this company Investor or expert role required ▾
—/5 · 0 investors

Sign in as an investor or expert to rate this company.
Technology No signals collected yet ▾
No technology data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.
Team & hiring No signals collected yet ▾
No team & hiring data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.
Market & funding stage 1 of 3 signals present ▾
Funding stage
not provided
Lifecycle stage
not provided
Latest round stage
series_b observed
Timeline 1 events ▾
  1. 2026-09-15 series_b · $40M · Led by Catalio Capital Management

Evidence & scoring

Why this score? none_required ▾

VentureSignalScore 53.7/100 for evvy, composed from 2 of 4 components (emerging formula), discounted ×0.85 for 50% signal coverage

ComponentWeightNormalizedContribution
funding_recency 0.2 0.9195 0.1839
funding_magnitude 0.3 0.4408 0.1322

Evidence this score rests on

Narrative vs. reality No SEC filing found for this round

Reported narrative · Tier 2
$40M series b
announced 2026-09-15 · source ↗
Filed reality · Tier 0 · SEC
No SEC Form D on record.

An evidence gap, not proof of falsity: Form D is not always required (foreign offerings, certain exemptions) or may not be filed yet.

Financing events four different events, four different dates

A first sale, a filing, an amendment and a public announcement are not the same event, and one date may not stand in for another. Where the latest financing date cannot be established from what we hold, this says unknown rather than substituting a date we do have.

Latest established financing date
2026-09-15
Money moved on or after
2026-09-15
Total reported by
not established
Basis
reported round

A reported round dated 2026-09-15 by its own source.

Raw observations 82 records ▾
AttributeValueKindSourceObservedStateConf.
common_name Evvy observed artifact ↗ 2026-09-28 normalized 0.90
community.hn.max_points 314 observed artifact ↗ 2026-09-30 superseded 0.20
community.hn.max_points 0 observed artifact ↗ 2026-10-08 normalized 0.20
community.hn.mentions 50 observed artifact ↗ 2026-09-30 superseded 0.20
community.hn.mentions 0 observed artifact ↗ 2026-10-08 normalized 0.20
community.hn.rumors [] observed artifact ↗ 2026-09-30 normalized 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=20433301", "title": "Ask HN: How do you deal with professional envy?", "points": 314, "created_at": "2019-07-14"} observed artifact ↗ 2019-07-14 superseded 0.20
community.hn.top_story {} observed artifact ↗ 2026-10-08 normalized 0.20
description Accelerate precision diagnostics and medicine for women's health observed derived 2026-10-01 normalized 0.60
funding.round.amount_usd 40000000 observed artifact ↗ 2026-09-15 normalized 0.90
funding.round.announced_on 2026-09-15 observed artifact ↗ 2026-09-15 normalized 0.90
funding.round.lead_investors ["Catalio Capital Management"] observed artifact ↗ 2026-09-15 normalized 0.90
funding.round.source_url https://siliconangle.com/2026/09/15/ai-startup-evvy-raises-40m-to-accelerate-precision-diagnostics-and-medicine-for-womens-health/ observed artifact ↗ 2026-09-15 normalized 0.90
funding.round.stage series_b observed artifact ↗ 2026-09-15 normalized 0.90
metric.venture.funding_amount_usd 40000000 derived calc 2026-09-28 derived 0.90
metric.venture.funding_recency_days 13.9753 derived calc 2026-09-28 superseded 0.90
metric.venture.funding_recency_days 15.6507 derived calc 2026-09-30 superseded 0.90
metric.venture.funding_recency_days 15.7072 derived calc 2026-09-30 superseded 0.90
metric.venture.funding_recency_days 16.344 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 16.3827 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 16.4726 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 16.6283 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 16.719 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 16.7445 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 16.786 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 23.8891 derived calc 2026-10-08 superseded 0.90
metric.venture.funding_recency_days 24.3089 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 24.56 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 24.8514 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 24.9519 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 25.126 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.1268 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.214 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.3077 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.419 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.5125 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.6039 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.6913 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.7801 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.8343 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 25.9221 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 26.0218 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.1081 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.1086 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.1403 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.2221 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.3229 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.3787 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.4189 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.5083 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.5981 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.6875 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.7777 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.8695 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 26.959 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 27.0402 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 27.0935 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 27.1364 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 27.2083 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 27.9933 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 28.0415 derived calc 2026-10-13 superseded 0.90
metric.venture.funding_recency_days 28.0948 derived calc 2026-10-13 superseded 0.90
metric.venture.funding_recency_days 28.2743 derived calc 2026-10-13 superseded 0.90
metric.venture.funding_recency_days 29.3782 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 29.4705 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 29.58 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 29.675 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 29.7722 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 29.8673 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 29.9626 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 30.0597 derived calc 2026-10-15 derived 0.90
score.venture_signal 55.2 derived calc 2026-09-28 superseded 0.60
score.venture_signal 55 derived calc 2026-09-30 superseded 0.60
score.venture_signal 54.9 derived calc 2026-10-01 superseded 0.60
score.venture_signal 54.3 derived calc 2026-10-08 superseded 0.60
score.venture_signal 54.2 derived calc 2026-10-09 superseded 0.60
score.venture_signal 54.1 derived calc 2026-10-10 superseded 0.60
score.venture_signal 54 derived calc 2026-10-11 superseded 0.60
score.venture_signal 53.9 derived calc 2026-10-12 superseded 0.60
score.venture_signal 53.8 derived calc 2026-10-13 superseded 0.60
score.venture_signal 53.7 derived calc 2026-10-14 derived 0.60
sector emerging derived calc 2026-10-01 normalized 0.50